CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants
Máchal, J., Hlinomaz, O., Kostolanská, K., Peš, O., Máchalová, A., Šplíchal, Z., Mot'ovská, Z., Juřica, J.
Published in Xenobiotica (02.08.2020)
Published in Xenobiotica (02.08.2020)
Get full text
Journal Article
CYP2C19 and CYP3A4 activity is associated with survival in ticagrelor-treated patients after ST-elevation myocardial infarction
Máchal, J., Hlinomaz, O., Kostolanská, K., Peš, O., Šplíchal, Z., Máchalová, A., Pokorný, J., Moťovská, Z., Juřica, J.
Published in Atherosclerosis (01.08.2023)
Published in Atherosclerosis (01.08.2023)
Get full text
Journal Article
CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in patients with stemi treated by prasugrel or ticagrelor
Machal, J., Hlinomaz, O., Kostolanska, K., Pes, O., Machalova, A., Jurica, J.
Published in Atherosclerosis (01.08.2018)
Published in Atherosclerosis (01.08.2018)
Get full text
Journal Article
Rare Envenomation with Crotalus oreganus in Slovak Republic
Klobusicka, Z, Plackova, S, Kostolanska, K, Mackova, J, Knapp, D, Bizik, A, Herman, O, Urbanova, E
Published in Clinical toxicology (Philadelphia, Pa.) (01.06.2008)
Get full text
Published in Clinical toxicology (Philadelphia, Pa.) (01.06.2008)
Journal Article